Diane Tang‐Liu

1.0k total citations
34 papers, 826 citations indexed

About

Diane Tang‐Liu is a scholar working on Ophthalmology, Pharmacology and Molecular Biology. According to data from OpenAlex, Diane Tang‐Liu has authored 34 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 10 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Diane Tang‐Liu's work include Glaucoma and retinal disorders (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Advanced Drug Delivery Systems (6 papers). Diane Tang‐Liu is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Advanced Drug Delivery Systems (6 papers). Diane Tang‐Liu collaborates with scholars based in United States, Ireland and United Kingdom. Diane Tang‐Liu's co-authors include Andrew Acheampong, Martha Shackleton, Du‐Shieng Chien, Devin Welty, Charles Gluchowski, Jie Shen, P. J. Burke, Larry A. Wheeler, B. A. John and J. Burke and has published in prestigious journals such as The American Journal of Gastroenterology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Diane Tang‐Liu

34 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Tang‐Liu United States 15 341 312 192 183 163 34 826
Mayssa Attar United States 13 566 1.7× 188 0.6× 76 0.4× 351 1.9× 158 1.0× 34 971
Michael C. Makoid United States 11 174 0.5× 178 0.6× 159 0.8× 66 0.4× 115 0.7× 26 517
Sukhbir S. Chrai United States 7 355 1.0× 375 1.2× 354 1.8× 132 0.7× 161 1.0× 7 806
Allan J. Flach United States 16 982 2.9× 305 1.0× 52 0.3× 236 1.3× 93 0.6× 48 1.3k
C. Debbasch France 16 719 2.1× 788 2.5× 71 0.4× 568 3.1× 147 0.9× 26 1.4k
Siew Kwan Koh Singapore 15 315 0.9× 375 1.2× 29 0.2× 230 1.3× 261 1.6× 29 865
Kai Bruns Germany 13 345 1.0× 177 0.6× 16 0.1× 114 0.6× 252 1.5× 19 727
Aude Pauly France 14 1.2k 3.6× 1.3k 4.1× 109 0.6× 870 4.8× 96 0.6× 18 1.8k
Hossein M. Elbadawy Saudi Arabia 13 29 0.1× 79 0.3× 58 0.3× 114 0.6× 148 0.9× 50 570
Pekka Suhonen Finland 14 76 0.2× 124 0.4× 226 1.2× 92 0.5× 217 1.3× 24 609

Countries citing papers authored by Diane Tang‐Liu

Since Specialization
Citations

This map shows the geographic impact of Diane Tang‐Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Tang‐Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Tang‐Liu more than expected).

Fields of papers citing papers by Diane Tang‐Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Tang‐Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Tang‐Liu. The network helps show where Diane Tang‐Liu may publish in the future.

Co-authorship network of co-authors of Diane Tang‐Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Tang‐Liu. A scholar is included among the top collaborators of Diane Tang‐Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Tang‐Liu. Diane Tang‐Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kompella, Uday B., Abraham J. Domb, Arto Urtti, et al.. (2019). ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. 35(8). 457–465. 5 indexed citations
2.
Tang‐Liu, Diane & Andrew Acheampong. (2005). Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye. Clinical Pharmacokinetics. 44(3). 247–261. 61 indexed citations
3.
Dong, Jennifer, Darius Babusis, Devin Welty, et al.. (2004). Effects of the Preservative Purite ® on the Bioavailability of Brimonidine in the Aqueous Humor of Rabbits. Journal of Ocular Pharmacology and Therapeutics. 20(4). 285–292. 32 indexed citations
4.
Shen, Jie, et al.. (2003). Evaluation of an Immortalized Retinal Endothelial Cell Line as an In Vitro Model for Drug Transport Studies Across the Blood-Retinal Barrier. Pharmaceutical Research. 20(9). 1357–1363. 33 indexed citations
5.
Acheampong, Andrew, et al.. (2002). Formulation Effects on Ocular Absorption of Brimonidine in Rabbit Eyes. Journal of Ocular Pharmacology and Therapeutics. 18(4). 325–337. 36 indexed citations
6.
Acheampong, Andrew, Martha Shackleton, B. A. John, et al.. (2002). Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes. Drug Metabolism and Disposition. 30(4). 421–429. 97 indexed citations
7.
8.
Madhu, C, et al.. (1998). Penetration of Natural Prostaglandins and Their Ester Prodrugs and Analogs Across Human Ocular Tissues in Vitro. Journal of Ocular Pharmacology and Therapeutics. 14(5). 389–399. 12 indexed citations
9.
Acheampong, Andrew, et al.. (1998). Cyclosporine Distribution into the Conjunctiva, Cornea, Lacrimal Gland, and Systemic Blood Following Topical Dosing of Cyclosporine to Rabbit, Dog, and Human Eyes. Advances in experimental medicine and biology. 30(1). 1001–1004. 12 indexed citations
10.
Chien, Du‐Shieng, Diane Tang‐Liu, & David F. Woodward. (1997). Ocular Penetration and Bioconversion of Prostaglandin F2α Prodrugs in Rabbit Cornea and Conjunctiva. Journal of Pharmaceutical Sciences. 86(10). 1180–1186. 14 indexed citations
11.
Madhu, C, et al.. (1997). Metabolic Deesterification of Tazarotene in Human Blood and Rat and HumanLiver Microsomes. Journal of Pharmaceutical Sciences. 86(8). 972–974. 29 indexed citations
12.
13.
Acheampong, Andrew, et al.. (1995). Comparison of Concentration-Time Profiles of Levobunolol and Timolol in Anterior and Posterior Ocular Tissues of Albino Rabbits. Journal of Ocular Pharmacology and Therapeutics. 11(4). 489–502. 27 indexed citations
14.
Tang‐Liu, Diane, et al.. (1995). Availability of 0.3% Ofloxacin Ointment and Solution in Human Conjunctiva and Aqueous Humor. Journal of Ocular Pharmacology and Therapeutics. 11(1). 57–63. 2 indexed citations
15.
Tang‐Liu, Diane, et al.. (1994). The Effect of Pilocarpine on Ocular Levobunolol Absorption from Ophthalmic Solutions. Journal of Ocular Pharmacology and Therapeutics. 10(4). 605–615. 1 indexed citations
16.
Hsyu, Poe‐Hirr, et al.. (1994). Pharmacokinetics of a novel retinoid AGN 190168 and its metabolite AGN 190299 after intravenous administration of AGN 190168 to rats. Biopharmaceutics & Drug Disposition. 15(5). 347–357. 5 indexed citations
17.
Tang‐Liu, Diane, et al.. (1992). Precorneal Sampling Techniques for Ophthalmic Gels. Journal of Ocular Pharmacology and Therapeutics. 8(2). 151–159. 9 indexed citations
18.
Tang‐Liu, Diane, et al.. (1989). Ocular Biodistribution of Clonidine After Topical Application with Ophthalmic Rods or Solution. Journal of Ocular Pharmacology and Therapeutics. 5(2). 133–140. 2 indexed citations
19.
Tang‐Liu, Diane, et al.. (1988). Ocular Metabolism of Levobunolol. Journal of Ocular Pharmacology and Therapeutics. 4(3). 269–278. 8 indexed citations
20.
Tang‐Liu, Diane & P. J. Burke. (1988). The Effect of Azone on Ocular Levobunolol Absorption: Calculating the Area Under the Curve and Its Standard Error Using Tissue Sampling Compartments. Pharmaceutical Research. 5(4). 238–241. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayssa Attar Breakdown of academic impact, for papers by Michael C. Makoid Breakdown of academic impact, for papers by Sukhbir S. Chrai Breakdown of academic impact, for papers by Allan J. Flach Breakdown of academic impact, for papers by C. Debbasch Breakdown of academic impact, for papers by Siew Kwan Koh Breakdown of academic impact, for papers by Kai Bruns Breakdown of academic impact, for papers by Aude Pauly Breakdown of academic impact, for papers by Hossein M. Elbadawy Breakdown of academic impact, for papers by Pekka Suhonen
Rankless by CCL
2026